Diagnosing hyperglycaemia in patients with chronic liver disease

Not Applicable

Completed

• Conditions: diabetes; liver disease; Metabolic and Endocrine - Diabetes; Oral and Gastrointestinal - Other diseases of the mouth, teeth, oesophagus, digestive system including liver and colon

• Registration Number: ACTRN12619001490167
• Lead Sponsor: Endocrinology services, Canterbury District Health Board

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2019-10-29
• Study Completion: 2021-05-26
• Last Update Posted: 21 July 2021

Recruitment & Eligibility

• Status: Completed
• Sex: All
• Target Recruitment: 21

Inclusion Criteria

Severe liver disease defined as: Biopsy Stage 4 cirrhosis or liver stiffness measured as greater or equal to 12.5kpa on Fibroscan.

Exclusion Criteria

A pre-existing diagnosis of diabetes.
On medications or treatments or underlying disease that is likely to shorten red cell survival or interfere with interpretation of laboratory HbA1c. .

Study & Design

• Study Type: Interventional
• Study Design: Not specified